Telemonitoring in patients with chronic heart failure and COPD.

Quality assessment of an integrated care pathway using telemonitoring in patients with chronic heart failure and COPD

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON26920

Enrollment

Registered

2017-12-11

Start date

2018-02-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD, chronic heart failure

Interventions

During a period of 2 years patients receive a personalized set of sensors for monitoring relevant vital signs (e.g. blood pressure, weight, oxygen saturation, energy expenditure and/or temperature). S

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with both CHF (HFrEF, HFpEF or HFmrEF) and COPD regardless of aetiology. 2. At least one hospital admission during the last year (due to CHF/COPD). 3. Age =/> 16 year. 4. Able to speak and read the Dutch language. 5. Life expectancy > 2.5 years. 6. Sufficient digital skills (or caregiver).

Exclusion criteria

Exclusion criteria: 1. Patients that do not have an internet connection. 2. Patients with psychological disorders preventing participation.

Design outcomes

Primary

Measure	Time frame
The primary endpoint is to investigate whether TM in patients with combined HF and COPD results in improved quality of life (EQ-5D), as compared to usual care.	—

Secondary

Measure	Time frame
1. To investigate whether TM in patients with combined HF and COPD results in improved HRQoL (MLHFQ, SGRQ). 2. To investigate whether TM results in improved levels of self-management as compared to usual care (PAM13). 3. To investigate patient satisfaction with TM compared to usual care (CQi) 4. To investigate whether patients are compliant to the TM program. 5. To assess health-care costs of TM compared with usual care.	—

Measure

Time frame

1. To investigate whether TM in patients with combined HF and COPD results in improved HRQoL (MLHFQ, SGRQ). 2. To investigate whether TM results in improved levels of self-management as compared to usual care (PAM13). 3. To investigate patient satisfaction with TM compared to usual care (CQi) 4. To investigate whether patients are compliant to the TM program. 5. To assess health-care costs of TM compared with usual care.

—

Contacts

Public ContactC. Herkert

Máxima Medical Centre

cyrille.herkert@mmc.nl+31 40-888 8200

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)